| Phase 4 |
| NCT05348876 |
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real… |
Non-metastatic Castration-resistant Prostate Cancer |
Recruiting |
2026-07-06 |
| NCT07298044 |
A Study to Learn More About the Change in the Blood Levels of Transthyretin When… |
Transthyretin Amyloid Cardiomyopathy |
Recruiting |
2026-06-29 |
| NCT04597125 |
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs… |
Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
Active, Not Recruiting |
2026-07-06 |
| Phase 3 |
| NCT05457283 |
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use… |
Chronic Kidney Disease |
Recruiting |
2026-08-20 |
| NCT06452277 |
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With… |
Advanced Non-small Cell Lung Cancer, HER2 Mutation |
Recruiting |
2026-08-19 |
| NCT07192952 |
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time… |
Left Ventricular Systolic Dysfunction |
Recruiting |
2026-06-29 |
| NCT07188805 |
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves… |
Left Ventricular Systolic Dysfunction |
Recruiting |
2026-06-15 |
| NCT05196035 |
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it… |
Chronic Kidney Disease |
Active, Not Recruiting |
2026-08-19 |
| NCT05587296 |
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to… |
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer |
Active, Not Recruiting |
2026-07-09 |
| NCT04464226 |
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in… |
Cancer |
Active, Not Recruiting |
2026-07-07 |
| NCT05794906 |
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo… |
Biochemically Recurrent Prostate Cancer |
Active, Not Recruiting |
2026-07-07 |
| NCT02562235 |
Riociguat in Children With Pulmonary Arterial Hypertension (PAH) |
Hypertension, Pulmonary |
Active, Not Recruiting |
2026-07-01 |
| NCT07023341 |
A Study to Learn More About How Well Aficamten Works in Japanese Participants With… |
Obstructive Hypertrophic Cardiomyopathy |
Active, Not Recruiting |
2026-06-26 |
| Phase 2 |
| NCT07211685 |
A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome |
Alport Syndrome |
Recruiting |
2026-08-20 |
| NCT07450599 |
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy… |
High-risk Localized Prostate Cancer |
Recruiting |
2026-08-10 |
| NCT06760819 |
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets… |
Advanced Solid Tumors |
Recruiting |
2026-07-07 |
| NCT06246643 |
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who… |
Solid Malignant Tumors |
Active, Not Recruiting |
2026-08-26 |
| NCT07625215 |
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial… |
Atrial Fibrillation |
Not Yet Recruiting |
2026-07-30 |
| NCT07566429 |
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease… |
Parkinson Disease |
Not Yet Recruiting |
2026-07-29 |
| NCT05059236 |
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation… |
Metastatic Hormone-sensitive Prostate Cancer |
Active, Not Recruiting |
2026-05-01 |
| Phase 1/2 |
| NCT05099172 |
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung… |
Advanced Non-small Cell Lung Cancer |
Recruiting |
2026-08-12 |
| NCT06914128 |
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors |
MTAP-deleted Solid Tumors |
Recruiting |
2026-06-26 |
| NCT03588299 |
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to… |
Hemophilia A |
Active, Not Recruiting |
2026-07-06 |
| NCT02637687 |
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of… |
Solid Tumors Harboring NTRK Fusion |
Active, Not Recruiting |
2025-06-22 |
| Phase 1 |
| NCT06659341 |
A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have… |
Advanced Solid Tumors Harboring KRAS G12C Mutation |
Recruiting |
2026-08-26 |